2.
Battegay EJ (1995) Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. J Mol Med 73:333–346
3.
Orredson SU, Knighton DR, Scheuenstuhl H, Hunt TK (1983) A quantitative in vitro study of fibroblast and endothelial cell migration in response to serum and wound fluid. J Surg Res 35:249–258
4.
Nissen NN, Polverini PJ, Koch AE, Volin MV, Gamelli RL, DiPietro LA (1998) Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 152:1445–1452
5.
Reed MJ, Puolakkainen P, Lane TF, Dickerson D, Bornstein P, Sage EH (1993) Differential expression of SPARC and thrombospondin-1 in wound repair: immunolocalization and in situ hybridization. J Histochem Cytochem 41:1467–1477
6.
Di Pietro LA, Nissen NN, Gamelli RL, Koch AE, Pyle JM, Polverini PJ () Thrombospondin 1 synthesis and function in wound repair. Am J Pathol 148:1851–1860
7.
Martin P (1997) Wound healing–aiming for perfect skin regeneration. Science (Washington, DC) 276:75–81
8.
Nissen NN, Polverini PJ, Gamelli RL, DiPietro LA (1996) Basic fibroblast growth factor mediates angiogenic activity in early surgical wounds. Surgery (St. Louis) 119:457–465
9.
Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF, van de WL (1992) Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 176:1375–1379
10.
Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? The Lancet 357:539–545CrossRef
11.
Lohsiriwat V, Curigliano G, Rietjens M et al (2011) Autologous fat transplantation in patients with breast cancer: ‘‘silencing’’ or ‘‘fueling’’ cancer recurrence? The Breast 20(4):351–357
12.
Heer K, Kumar H, Read JR, Fox JN, Monson JRT, Kerin MJ (2001) Serum vascular endothelial growth factor in breast cancer. Its relation with cancer type and estrogen receptor status. Clin Cancer Res 7:3491–3494PubMed
13.
Sliutz G, Tempfer C, Obermair A, Dadak C, Kainz C (1995) Serum evaluation of basic FGF in breast cancer patients. Anticancer Res 15(6B):2675–2677